Gut microbial communities modulate efficacy of albendazole-ivermectin against soil-transmitted helminthiases

Background: Soil-transmitted helminth infections represent a large burden across the globe with over a quarter of the worlds population at risk. The outcome of available treatments is species-specific with a large proportion of unexplained treatment failure. Administration of albendazole is the standard of care, but because of low cure rates (CR) observed in treating Trichuris trichiura infections, a significantly more efficacious alternative therapy combining albendazole and ivermectin is being investigated. Methods: 80 patients from the village of Pak-Khan, in Laos, with confirmed STH infections (Trichuris trichiura and hookworms), received either albendazole (400 mg) or albendazole (400 mg) and ivermectin (200 ug/kg) together. A pre-treatment stool sample was collected as well as daily post-treatment stool samples for up to 28 days to measure treatment efficacy. Taxonomic profiling of pre-treatment stool samples was conducted using 16S rRNA gene sequencing, target-specific and total bacteria qPCR, as well as shotgun sequencing. Results: Three bacterial communities, or enterotypes (ET) 1-3, were identified. No association with pre-treatment enterotype and treatment outcome of both Trichuris trichiura and hookworm were found in the monotherapy arm with overall cure rates (CR) of 7.5% and 50%, respectively. Pre-treatment enterotype was strongly associated with efficacy of the combination therapy for both, T. trichiura (CRoverall = 33.3%; CRET1 = 5.8%; CRET2 = 16.6%; CRET3 = 68.5%) and hookworm (CRoverall = 47.2%; CRET1 = 31.2%; CRET2 = 16.6%; CRET3 = 78.5%) infections. Daily post-treatment egg per gram of stool counts recapitulated these observations and faster and increased egg reduction was observed in ET3 when compared to failure-associated ET1 and ET2. Species-level comparisons of these enterotypes highlighted a set of ten differentially enriched bacterial species. Conclusion: Taxonomically distinct gut microbiota communities were found in this setting in terms of both, relative and absolute abundances, of specific bacterial taxa. Pre-treatment enterotype was relevant for treatment outcome of the combination therapy, albendazole and ivermectin, for T. trichiura as well as for hookworm infections. These observations indicate that pre-treatment microbial composition of stool samples should be monitored to ensure evidence-based administration of albendazole-ivermectin to treat these diseases.

comparable between both treatment arms ( Figure S2). Accuracy of this enterotype- classification accuracy included the genera Faecalibacterium (2.704%), 1 5 0 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) observe any association between cure rate, defined as an average egg per gram 1 7 7 count (EPG) equal to zero between days 14-28 post-treatment, and ET, for patients 1 7 8 receiving albendazole monotherapy for T. trichiura ( Figure 3A, right half) nor 1 7 9 hookworm infections ( Figure 3B, right half). However, the majority of patients who  average egg counts between days 14-28 post-treatment for the combination therapy Species-level features enriched in either failure-or success-associated enterotype in 1 9 5 the albendazole-ivermectin treatment arm. To identify species-level differences 1 9 6 between failure-associated enterotypes 1-2 and success-associated enterotype 3, we 1 9 7 generated shotgun sequencing data from samples collected within the albendazole 1 9 8 plus ivermectin treatment arm. In addition to previously observed enriched features 1 9 9 from Prevotella (P. copri in ET1), Faecalibacterium (F. prausnitzii in ET1), 2 0 0 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 7, 2021. when comparing both groups ( Figure 3C). Coprococcus eutactus was also depleted 2 0 4 in ET3 when comparing it to ET2 while Anaerostipes hadrus was enriched in the 2 0 5 former. therapy. This association remains true when adjusting for potential confounders such 2 1 2 as sex, age, and infection intensities ( Table 2). Faster clearance is also observed for clearance was not different between patients presenting ET2 and ET1 for both, T. trichiura and hookworm infections, with the combination therapy. We did not observe 2 1 8 any association between enterotype and probability of being cured in the 2 1 9 monotherapy arm.  Associations between success-and failure-associated enterotypes and daily post- treatment eggs per gram of stool counts. In a survival analysis, we confirm that 2 2 8 patients presenting ET3 pre-treatment are more likely to be both, faster and more efficiently cured from a T. trichiura infestation using the albendazole and ivermectin-2 3 0 based treatment than those presenting ET1 and ET2 (P = 0.0002; Figure 5A, left- . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 7, 2021. ; 16% cure in this time frame, respectively. Daily egg patterns also largely reflect these 2 3 5 findings ( Figure 5B). A sharp decrease of EPG counts is observed immediately 2 3 6 following treatment, irrespective of treatment arm or baseline enterotype. For T. Discussion.

4 6
This study is the first to investigate gut microbial determinants of antiparasitic terms of both, relative and absolute abundance of specific taxa, and ii) that pre- well as for hookworm infections. These observations indicate that pre-treatment 2 5 5 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) which colonize the small intestine, as well as for T. trichiura, which resides in the treatment response could be improved through a microbiome-based therapy.

9 1
Therapeutic opportunities derived from these findings could, for instance, involve 2 9 2 targeted disruption of hypothetically resistant strains or overall community 2 9 3 displacement with fitter, macrolide-sensitive strains to mitigate resistance potential. The other important implication of this study is that ivermectin, which is marketed as isolates, which could hinder efforts involved in antibiotic stewardship programs. This diversity-based classification might change in a larger cohort. In addition, the 3 0 5 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) human populations to date, we believe that the study setting is representative of an 3 1 7 environment with normal parasitic sensitivity.

1 8
In conclusion, we showed in this study that the gut microbiota composition is an failure-associated features, and -perhaps more importantly -to optimized, evidence-3 2 5 based use of these powerful drugs. Methods.

2 8
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted cox proportional hazard were generated and measured using the "survfit" and 4 1 8 "coxph" 54 functions from the survival package, respectively. The heat tree analysis 4 1 9 was performed on the MicrobiomeAnalyst platform 55 using Metacoder R package 56 .

2 0
All graphs, besides the heat tree, were generated using the OriginPro 2021 graphing  Funding 4 2 7 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) project supervision, writing of the initial manuscript, manuscript editing.  The authors declare that they have no competing interests Gut microbial community composition of patients infected with Trichuris trichiura 4 5 1 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted October 7, 2021. ; Performance of classification in this dataset using a random forest model. Taxonomic   4  5  3 features are ranked according to their individual contribution to sample classification.  drug ivermectin: from an antiparasitic agent to a repositioned cancer drug.

4 8
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. transporters involved in intrinsic resistance to antimicrobial agents.

6 5
Antimicrobial agents and chemotherapy 49, 4781-4783 (2005).   Emergence of macrolide resistance gene mph (B) in Streptococcus uberis and 5 7 2 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity (which was not certified by peer review) The copyright holder for this pre this version posted October 7, 2021.  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity (which was not certified by peer review) The copyright holder for this pre this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.07.21264625 doi: medRxiv preprint